NUVB
Nuvation Bio Inc.$5.86-0.04 (-0.76%)Prev Close$5.90·MCap$2.02B·P/E—·Vol3.77M·Yield—
▲
Buys (12M)
1
$118.3K
▼
Sells (12M)
13
$8.97M
◆
Net Activity
Net Seller
$8.85M
●
Active Insiders
7
last 12 mo
Over the past 12 months, insider activity at Nuvation Bio Inc. (NUVB) has been dominated by selling, with 1 insider purchase totaling $118.3K and 13 insider sales totaling $8.97M. The most recent insider transaction was by Sauvage Philippe (officer: Chief Financial Officer), who sold $286.4K worth of shares on Jun 24, 2026. Nuvation Bio Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $2.02B.
NUVB Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | Sauvage Philippe | officer: Chief Financial Officer | Sell | 47,668 | $6.01 | $286.4K | 12,673-79% |
| Jun 24, 2026 | Markel Stacy | officer: CHIEF PEOPLE OFFICER | Sell | 125,000 | $6.03 | $753.2K | 32,591-79% |
| Jun 24, 2026 | Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | Sell | 63,000 | $6.02 | $379.2K | 53,000-54% |
| Jun 11, 2026 | Mashal Robert | director | Buy | 25,000 | $4.73 | $118.3K | 225,000 |
| Apr 21, 2026 | Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | Sell | 36,750 | $5.01 | $184.3K | 53,000-41% |
| Apr 21, 2026 | Liu Dongfang | officer: CHIEF MEDICAL OFFICER | Sell | 50,000 | $5.02 | $251.0K | 18,000-74% |
| Apr 8, 2026 | Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | Sell | 200,000 | $4.52 | $903.6K | 53,000-79% |
| Dec 1, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | 150,000 | $7.82 | $1.17M | 0 |
| Nov 25, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | 20,000 | $7.75 | $155.0K | 0 |
| Nov 20, 2025 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Sell | 369,051 | $7.23 | $2.67M | 0 |
| Nov 20, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | 20,000 | $7.00 | $140.1K | 0 |
| Nov 19, 2025 | Hanley David C. | CHIEF TECHNICAL OPERATIONS | Sell | 200,000 | $7.14 | $1.43M | 0 |
| Nov 17, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | 30,000 | $4.93 | $148.0K | 0 |
| Oct 27, 2025 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Sell | 100,000 | $5.02 | $502.5K | 0 |
| Jun 18, 2025 | Markel Stacy | CHIEF PEOPLE OFFICER | Buy | 10,000 | $1.71 | $17.1K | 0 |
| Jun 16, 2025 | Hung David | PRESIDENT AND CEO | Buy | 500,000 | $1.79 | $893.5K | 0 |
| Jun 16, 2025 | Sauvage Philippe | Chief Financial Officer | Buy | 7,300 | $1.81 | $13.2K | 0 |
| Jun 16, 2025 | Sjogren Colleen | Chief Commercial Officer | Buy | 50,000 | $1.81 | $90.3K | 0 |
| Jun 16, 2025 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Buy | 50,000 | $1.79 | $89.7K | 0 |
| May 2, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | 20,000 | $2.50 | $50.0K | 0 |
| Apr 4, 2025 | Hung David | PRESIDENT AND CEO | Buy | 500,000 | $1.64 | $820.2K | 0 |
| Apr 1, 2025 | Mashal Robert | Director | Buy | 100,000 | $1.67 | $167.0K | 0 |
| Nov 13, 2024 | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | Sell | 56,361 | $2.89 | $162.9K | 3,866,228 |
| Oct 10, 2024 | Mashal Robert | Buy | 100,000 | $2.20 | $220.0K | 100,000 | |
| Jun 26, 2024 | Cui Xiangmin | Buy | 277,895 | $2.97 | $825.3K | 2,453,131 | |
| Jun 25, 2024 | Cui Xiangmin | Buy | 500,000 | $2.98 | $1.49M | 2,175,236+30% | |
| Jun 13, 2024 | BLICKENSTAFF KIM D | Buy | 172,189 | $2.90 | $500.1K | 172,189 | |
| Sep 21, 2023 | NODELMAN OLEG | Director | Buy | 5,313,100 | $1.26 | $6.69M1.5% OS | 12,674,775+72% |
| Dec 5, 2022 | FALBERG KATHRYN E | Director | Buy | 250,000 | $1.94 | $483.8K | 250,000 |
| Apr 7, 2022 | Omega Fund V, L.P. | 10% Owner | Sell | 2,500,000 | $5.60 | $14.00M0.7% OS | 20,457,340 |
| Dec 17, 2021 | Omega Fund V, L.P. | 10% Owner | Sell | 500,000 | $10.07 | $5.04M | 22,957,340 |
| Dec 9, 2021 | Omega Fund V, L.P. | 10% Owner | Sell | 1,400,000 | $9.80 | $13.72M | 23,457,340 |
| Nov 30, 2021 | NODELMAN OLEG | Director | Buy | 393,168 | $8.89 | $3.49M | 7,361,675 |
| Nov 30, 2021 | NODELMAN OLEG | Director | Sell | 208,142 | $9.96 | $2.07M | 1,147,483 |
| Nov 24, 2021 | Omega Fund V, L.P. | 10% Owner | Sell | 295,036 | $9.76 | $2.88M | 24,857,376 |
| Nov 5, 2021 | Omega Fund V, L.P. | 10% Owner | Sell | 2,000,000 | $9.25 | $18.50M0.6% OS | 25,152,376 |
| Nov 1, 2021 | Omega Fund V, L.P. | 10% Owner | Sell | 1,060,000 | $9.59 | $10.16M | 27,197,376 |
| Apr 13, 2021 | NODELMAN OLEG | Director | Buy | 464,500 | $9.89 | $4.59M | 6,990,265 |
| Apr 1, 2021 | Bazemore Robert B | Director | Buy | 5,000 | $9.98 | $49.9K | 5,000 |
NUVB Insider Buying Activity
The following table shows recent insider purchases of Nuvation Bio Inc. (NUVB) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Mashal Robert | director | Buy | 25,000 | $4.73 | $118.3K | 225,000 |
| Jun 18, 2025 | Markel Stacy | CHIEF PEOPLE OFFICER | Buy | 10,000 | $1.71 | $17.1K | 0 |
| Jun 16, 2025 | Hung David | PRESIDENT AND CEO | Buy | 500,000 | $1.79 | $893.5K | 0 |
| Jun 16, 2025 | Sauvage Philippe | Chief Financial Officer | Buy | 7,300 | $1.81 | $13.2K | 0 |
| Jun 16, 2025 | Sjogren Colleen | Chief Commercial Officer | Buy | 50,000 | $1.81 | $90.3K | 0 |
| Jun 16, 2025 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Buy | 50,000 | $1.79 | $89.7K | 0 |
| Apr 4, 2025 | Hung David | PRESIDENT AND CEO | Buy | 500,000 | $1.64 | $820.2K | 0 |
| Apr 1, 2025 | Mashal Robert | Director | Buy | 100,000 | $1.67 | $167.0K | 0 |
| Oct 10, 2024 | Mashal Robert | Buy | 100,000 | $2.20 | $220.0K | 100,000 | |
| Jun 26, 2024 | Cui Xiangmin | Buy | 277,895 | $2.97 | $825.3K | 2,453,131 | |
| Jun 25, 2024 | Cui Xiangmin | Buy | 500,000 | $2.98 | $1.49M | 2,175,236+30% | |
| Jun 13, 2024 | BLICKENSTAFF KIM D | Buy | 172,189 | $2.90 | $500.1K | 172,189 | |
| Sep 21, 2023 | NODELMAN OLEG | Director | Buy | 5,313,100 | $1.26 | $6.69M1.5% OS | 12,674,775+72% |
| Dec 5, 2022 | FALBERG KATHRYN E | Director | Buy | 250,000 | $1.94 | $483.8K | 250,000 |
| Nov 30, 2021 | NODELMAN OLEG | Director | Buy | 393,168 | $8.89 | $3.49M | 7,361,675 |
| Apr 13, 2021 | NODELMAN OLEG | Director | Buy | 464,500 | $9.89 | $4.59M | 6,990,265 |
| Apr 1, 2021 | Bazemore Robert B | Director | Buy | 5,000 | $9.98 | $49.9K | 5,000 |
NUVB Insider Selling Activity
The following table shows recent insider sales of Nuvation Bio Inc. (NUVB) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | Sauvage Philippe | officer: Chief Financial Officer | Sell | 47,668 | $6.01 | $286.4K | 12,673-79% |
| Jun 24, 2026 | Markel Stacy | officer: CHIEF PEOPLE OFFICER | Sell | 125,000 | $6.03 | $753.2K | 32,591-79% |
| Jun 24, 2026 | Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | Sell | 63,000 | $6.02 | $379.2K | 53,000-54% |
| Apr 21, 2026 | Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | Sell | 36,750 | $5.01 | $184.3K | 53,000-41% |
| Apr 21, 2026 | Liu Dongfang | officer: CHIEF MEDICAL OFFICER | Sell | 50,000 | $5.02 | $251.0K | 18,000-74% |
| Apr 8, 2026 | Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | Sell | 200,000 | $4.52 | $903.6K | 53,000-79% |
| Dec 1, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | 150,000 | $7.82 | $1.17M | 0 |
| Nov 25, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | 20,000 | $7.75 | $155.0K | 0 |
| Nov 20, 2025 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Sell | 369,051 | $7.23 | $2.67M | 0 |
| Nov 20, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | 20,000 | $7.00 | $140.1K | 0 |
| Nov 19, 2025 | Hanley David C. | CHIEF TECHNICAL OPERATIONS | Sell | 200,000 | $7.14 | $1.43M | 0 |
| Nov 17, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | 30,000 | $4.93 | $148.0K | 0 |
| Oct 27, 2025 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Sell | 100,000 | $5.02 | $502.5K | 0 |
| May 2, 2025 | Liu Dongfang | CHIEF MEDICAL OFFICER | Sell | 20,000 | $2.50 | $50.0K | 0 |
| Nov 13, 2024 | Wang Junyuan Jerry | CEO, ANHEART THERAPEUTICS LTD. | Sell | 56,361 | $2.89 | $162.9K | 3,866,228 |
| Apr 7, 2022 | Omega Fund V, L.P. | 10% Owner | Sell | 2,500,000 | $5.60 | $14.00M0.7% OS | 20,457,340 |
| Dec 17, 2021 | Omega Fund V, L.P. | 10% Owner | Sell | 500,000 | $10.07 | $5.04M | 22,957,340 |
| Dec 9, 2021 | Omega Fund V, L.P. | 10% Owner | Sell | 1,400,000 | $9.80 | $13.72M | 23,457,340 |
| Nov 30, 2021 | NODELMAN OLEG | Director | Sell | 208,142 | $9.96 | $2.07M | 1,147,483 |
| Nov 24, 2021 | Omega Fund V, L.P. | 10% Owner | Sell | 295,036 | $9.76 | $2.88M | 24,857,376 |
| Nov 5, 2021 | Omega Fund V, L.P. | 10% Owner | Sell | 2,000,000 | $9.25 | $18.50M0.6% OS | 25,152,376 |
| Nov 1, 2021 | Omega Fund V, L.P. | 10% Owner | Sell | 1,060,000 | $9.59 | $10.16M | 27,197,376 |
NUVB Insiders
Similar Stocks to NUVB
VRTX
Vertex Pharmaceuticals Incorporated
$476.29+0.08%
$126.50B
REGN
Regeneron Pharmaceuticals, Inc.
$662.73+1.01%
$68.29B
ALNY
Alnylam Pharmaceuticals, Inc.
$275.93-1.72%
$43.19B
RVMD
Revolution Medicines, Inc.
$185.71+0.42%
$40.34B
MRNA
Moderna, Inc.
$68.11+1.00%
$27.09B
INSM
Insmed Incorporated
$109.25-0.67%
$25.06B
INCY
Incyte Corporation
$114.43-0.30%
$23.32B
UTHR
United Therapeutics Corporation
$530.63+0.75%
$23.22B